Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station? Editorial Article uri icon

Overview

publication date

  • October 30, 2022

Identity

Scopus Document Identifier

  • 85142725564

Digital Object Identifier (DOI)

  • 10.1016/j.jtcvs.2022.10.031

PubMed ID

  • 36402582